Clinical Trial Update: Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease [Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 2 study investigating how SGLT2 inhibition may affect pediatric non-alcoholic fatty liver disease. The trial is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• SGLT2 inhibitor

Snippet

Sponsor: Justin Ryder | Conditions: Non-Alcoholic Fatty Liver Disease | Phase 2 | Status: RECRUITING